Nemeroff Resigns Psychiatry Chairmanship
By Staff Reporters
Senator Charles Grassley’s (R-Iowa) investigation into conflicts of interest among doctors has led Charles Nemeroff to step down from his chairmanship of Emory University’s psychiatry department. Nemeroff, a late career MD-PhD and prominent researcher in clinical depression, has been hit by a steady stream of criticism since Grassley alleged he failed to disclose hundreds of thousands in payments from GlaxoSmithKline.
Unreported Income Galore
According to the Wall Street Journal, December 23, 2008 Emory’s investigation turned up more than $800,000 in income from Glaxo that Nemeroff didn’t report to the university, for more than 250 speaking engagements over six years.
As a mea culpa, Emory won’t ask for research grants or other contracts involving Nemeroff for two years – a voluntary ban that would apply to National Institutes of Health [NIH] funding.
Assessment
Is this a black-eye for Emory University, or just a slight hematoma? Are other “shoes to drop?”
Conclusion
Your thoughts and comments on this Medical Executive-Post are appreciated.
Speaker:If you need a moderator or speaker for an upcoming event, Dr. David E. Marcinko; MBA – Publisher-in-Chief of the Medical Executive-Post – is available for seminar or speaking engagements. Contact: MarcinkoAdvisors@msn.com
Subscribe Now:Did you like this Medical Executive-Post, or find it helpful, interesting and informative? Want to get the latest ME-Ps delivered to your email box each morning? Just subscribe using the link below. You can unsubscribe at any time. Security is assured.
Link: http://feeds.feedburner.com/HealthcareFinancialsthePostForcxos
Filed under: Drugs and Pharma, Ethics, Information Technology | Tagged: Nemeroff | 5 Comments »














